Position in WGS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,021,953
-$21,656,725 QoQ
Shares Held
202,771
-24.0% QoQ
Ownership
0.683%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in WGS Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FRED ALGER MANAGEMENT, LLC holds $517,297,913 across 13 Diagnostics & Research names. WGS ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,756,472 | $351,276,835 | |
| 2 | GH |
Guardant Health, Inc.
|
622,259 | $57,478,063 | |
| 3 | ADPT |
Adaptive Biotechnologies Corp
|
2,063,146 | $28,636,466 | |
| 4 | RDNT |
RadNet, Inc.
|
341,938 | $19,110,914 | |
| 5 | VCYT |
Veracyte, Inc.
|
579,460 | $18,664,406 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
24,268 | $13,635,946 | |
| 7 | WGS |
GeneDx Holdings Corp.
This page
|
202,771 | $13,021,953 | |
| 8 | NEO |
Neogenomics Inc
|
651,649 | $4,835,235 |
All Filings in WGS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,021,953 | 202,771 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,678,678 | 266,636 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,495,717 | 357,302 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $75,742,478 | 820,523 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $49,332,299 | 557,018 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $41,969,710 | 546,054 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,731,121 | 394,230 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||